Asian markets ended mostly lower on Tuesday after a warning from drugmaker Moderna CEO that existing Covid-19 vaccines would be less effective against the Omicron variant than they have been against the Delta variant. South Korean shares declined on disappointing factory output data and continuance of corona virus curbs. However, Chinese shares ended up as a jump in manufacturing PMI curbed hopes of policy easing. The official manufacturing Purchasing Manager’s Index (PMI) was at 50.1 in November, up from 49.2 in October.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,563.89 | 1.19 | 0.03 |
Hang Seng | 23,475.26 | -376.98 | -1.58 |
Jakarta Composite | 6,533.93 | -74.36 | -1.13 |
KLSE Composite | 1,513.98 | 3.41 | 0.23 |
Nikkei 225 | 27,821.76 | -462.16 | -1.63 |
Straits Times | 3,041.29 | -79.29 | -2.54 |
KOSPI Composite | 2,839.01 | -70.31 | -2.42 |
Taiwan Weighted | 17,427.76 | 99.67 | 0.58 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: